Congress Daily Digest- An error has occurred; the feed is probably down. Try again later.
- Department of State News Feed
- An error has occurred; the feed is probably down. Try again later.
- Congressional Budget Office, CBO
- H.R. 7934, Settlement Agreement Information Database Act
- CBO’s Review of the Reconciliation Recommendations of the Senate Committee on Homeland Security and Governmental Affairs
- H.R. 8036, Interagency Coordination in Export Controls Act of 2026
- H.R. 6196, Locally Led Development and Humanitarian Response Act
- H.R. 3259, Post Quantum Cybersecurity Standards Act
- S. 2981, Prosthetics and Advancement Reform Act
- S. 1787, Dolores River National Conservation Area and Special Management Area Act
- H.R. 6541, Regulation A+ Improvement Act of 2025
- Legislation considered under suspension of the Rules of the House of Representatives during the week of May 18, 2026
- How Changes in Discretionary Funding for the Budget Year Affect Outlays, 2027 to 2036: An Interactive Tool
- The White House Blog
- An error has occurred; the feed is probably down. Try again later.
- World News Network
- An error has occurred; the feed is probably down. Try again later.
- U.S. Navy – POD
- Changes To Navy News Subscription Service
- Surface Warfare - Obtaining a Fix on Fleet NSS Skill Sets
- FY-17 Adm. Vern Clark and Gen. James L. Jones Safety Awards
- Top Schools Embrace WebTA Automation; Eliminate Navy College Funding Backlog
- Enlisted Credentialing and USMAP Completions Now Viewable in Electronic Training Jacket
- Department of the Navy Releases Fiscal Year 2019 Budget
- Navy Defense Foreign Language Testing Program
- Navy College Scheduler Tool Improved and Added to My Navy Portal
- Ready, Set, Wear: Guidelines for IFRV Wear Announced
- Naval War College Issues 'Call for Papers' on Women, Peace, Security
Register to Vote
Tag Archives: Smith Glaxo Kline
New FDA restrictions on GlaxoSmithKline Rosiglitazone – Avandia, Avandamet, Avandaryl
Opinion by Patricia L Johnson The Risk Evaluation and Mitigation Strategy (REM) evaluation conducted by the FDA in May of 2011 will be bringing about the following changes in the manner in which the drug Rosiglitazone – Avandia®, Avandamet®, Avandaryl® … Continue reading
ARTICLES and ANSWERS 2020 